ArticleThoracic cancer2022

Use of PD-1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report.

Li Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.